Ouédraogo, Joël
Ilboudo, Sylvain
Ouédraogo, Geoffroy Gueswindé
Somda, Gaétan Donzèo
Bonogo, Barthélemy
Dakuyo, Virginie
Ouédraogo, Salfo
Boly, Raïnatou
Nitiéma, Mathieu
Magnini, Dofini Réné
Semdé, Rasmané
Ouédraogo, Sylvin
Funding for this research was provided by:
Burkina Faso’s National Research and Innovation Fund for Development (n° AAP_Rapide Covid19_mala infect_1-04 FONRID, n° AAP_Rapide Covid19_mala infect_1-04 FONRID, n° AAP_Rapide Covid19_mala infect_1-04 FONRID, n° AAP_Rapide Covid19_mala infect_1-04 FONRID, n° AAP_Rapide Covid19_mala infect_1-04 FONRID)
Article History
Received: 23 April 2025
Accepted: 21 July 2025
First Online: 28 July 2025
Declarations
:
: The study protocol was approved by two Ethics Committee: the first one is the national ‘’Health Research Ethics Committee’’ under Deliberation number N°2021-04-104 of 21/04/2021, and the second is the “Institutional Ethics Committee for Health Sciences Research (CEIRES)’’ under the Deliberation number Réf-A09-2021/CEIRES of 31/03/2021.
: The authors declare no competing interests.